Aurinia Pharmaceuticals AUPH Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's change in lease liabilities?
- Aurinia Pharmaceuticals (AUPH) reported change in lease liabilities of -$214K in Q1 2026.
- How has Aurinia Pharmaceuticals's change in lease liabilities changed year-over-year?
- Aurinia Pharmaceuticals's change in lease liabilities decreased by 9.7% year-over-year, from -$195K to -$214K.
- What is the long-term trend for Aurinia Pharmaceuticals's change in lease liabilities?
- Over 3 years (2022 to 2025), Aurinia Pharmaceuticals's change in lease liabilities has grown at a 7.1% compound annual growth rate (CAGR), from -$652K to -$802K.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.